Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy...
-
Upload
charla-kathryn-bennett -
Category
Documents
-
view
214 -
download
1
Transcript of Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy...
![Page 1: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist.](https://reader035.fdocuments.us/reader035/viewer/2022062713/56649ccc5503460f94996966/html5/thumbnails/1.jpg)
Use of intra-operative frozen section in surgery for potential early stage
ovarian malignancy
September 2011Dr Paul Cross
Consultant Cellular PathologistQEH
Gateshead
![Page 2: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist.](https://reader035.fdocuments.us/reader035/viewer/2022062713/56649ccc5503460f94996966/html5/thumbnails/2.jpg)
Ovarian “cancer” - Clinical Problem• Want to try and diagnose as early as
possible to allow definitive surgical treatment (if this was applicable)
• Need tissue diagnosis to do so• Clinical discussion about possible use of
frozen section to help diagnose intra-operatively to prevent second procedure if possible
• Can diagnose and help stage in early stage disease
![Page 3: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist.](https://reader035.fdocuments.us/reader035/viewer/2022062713/56649ccc5503460f94996966/html5/thumbnails/3.jpg)
Frozen SectionsAdvantages
RapidAccurate (usually)Liked by surgeonsAre far more widely used elsewhere in the worldOne anaesthetic
DisadvantagesTime consuming (?)Costly (?)Stressful/?disliked by PathologistsNot that widely used in UK pathologyInaccurate (occasionally)
![Page 4: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist.](https://reader035.fdocuments.us/reader035/viewer/2022062713/56649ccc5503460f94996966/html5/thumbnails/4.jpg)
Why Gateshead?• Northern Gynaecological
Oncology Centre based at Gateshead
• Act as the Cancer Centre for women with Gynaecological malignancy for a population of approx 2,000,000 about 400 ovarian cancers/year
• High referral of cases of suspected ovarian malignancy (use of RMI >200)
![Page 5: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist.](https://reader035.fdocuments.us/reader035/viewer/2022062713/56649ccc5503460f94996966/html5/thumbnails/5.jpg)
Use of Ovarian Frozen Section Reporting
• Used in ovarian surgery to help decide if lesion is malignant or potentially malignant (borderline) or benign at the time of surgery
• If malignant or borderline then requires more tissue sampling to allow FIGO staging to assess possible extent of tumour involvement of other tissues
• If benign then requires no more surgery• QEH is, as far as is known, one of a few centres in
UK to routinely operate this ovarian FS service• Ovarian FS makes about 86% of all the FS we do
in our lab (n=195 for 2010)
![Page 6: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist.](https://reader035.fdocuments.us/reader035/viewer/2022062713/56649ccc5503460f94996966/html5/thumbnails/6.jpg)
Frozen Section Protocol• All cases are discussed prior to surgery in
MDT• Those with possible stage 1 or 2 ovarian
malignancy are put on theatre list for possible FS
• Laboratory are informed 24 hours in advance with details and approximate time
• Duty Pathologist (1 of 5) covers for FS• Porter brings directly to lab when available• FS processed (routinely 2 blocks) and
report phoned back to theatre
![Page 7: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist.](https://reader035.fdocuments.us/reader035/viewer/2022062713/56649ccc5503460f94996966/html5/thumbnails/7.jpg)
![Page 8: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist.](https://reader035.fdocuments.us/reader035/viewer/2022062713/56649ccc5503460f94996966/html5/thumbnails/8.jpg)
![Page 9: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist.](https://reader035.fdocuments.us/reader035/viewer/2022062713/56649ccc5503460f94996966/html5/thumbnails/9.jpg)
![Page 10: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist.](https://reader035.fdocuments.us/reader035/viewer/2022062713/56649ccc5503460f94996966/html5/thumbnails/10.jpg)
![Page 11: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist.](https://reader035.fdocuments.us/reader035/viewer/2022062713/56649ccc5503460f94996966/html5/thumbnails/11.jpg)
![Page 12: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist.](https://reader035.fdocuments.us/reader035/viewer/2022062713/56649ccc5503460f94996966/html5/thumbnails/12.jpg)
![Page 13: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist.](https://reader035.fdocuments.us/reader035/viewer/2022062713/56649ccc5503460f94996966/html5/thumbnails/13.jpg)
![Page 14: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist.](https://reader035.fdocuments.us/reader035/viewer/2022062713/56649ccc5503460f94996966/html5/thumbnails/14.jpg)
![Page 15: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist.](https://reader035.fdocuments.us/reader035/viewer/2022062713/56649ccc5503460f94996966/html5/thumbnails/15.jpg)
![Page 16: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist.](https://reader035.fdocuments.us/reader035/viewer/2022062713/56649ccc5503460f94996966/html5/thumbnails/16.jpg)
Frozen section reporting
Frozen section Paraffin section
![Page 17: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist.](https://reader035.fdocuments.us/reader035/viewer/2022062713/56649ccc5503460f94996966/html5/thumbnails/17.jpg)
The iceberg principle…..
![Page 18: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist.](https://reader035.fdocuments.us/reader035/viewer/2022062713/56649ccc5503460f94996966/html5/thumbnails/18.jpg)
Table 1 Overall frozen section reporting profile n=1439
PS Benign PS Borderline PS Malignant
FS Benign769 39 19
FS Borderline
8 102 82
FS Malignant3 2 415
![Page 19: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist.](https://reader035.fdocuments.us/reader035/viewer/2022062713/56649ccc5503460f94996966/html5/thumbnails/19.jpg)
Table 2 Overall frozen section reporting, combining borderline and malignant categories n=1439
PS Benign PS Borderline/Malignant
FS Benign 769 58
FS Borderline/Malignant
11 601
![Page 20: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist.](https://reader035.fdocuments.us/reader035/viewer/2022062713/56649ccc5503460f94996966/html5/thumbnails/20.jpg)
Table 3 Primary ovarian epithelial tumours (serous, mucinous, endometrioid, clear cell, urothelial/Brenner) of the ovary at frozen section n=982
PS Benign PS Borderline PS Malignant
FS Benign 417 38 8
FS Borderline 8 97 74
FS Malignant 1 2 337
![Page 21: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist.](https://reader035.fdocuments.us/reader035/viewer/2022062713/56649ccc5503460f94996966/html5/thumbnails/21.jpg)
Summary - 1• Median time for reporting 20 minutes
(range 10-45, mean 18.5 minutes)• Overall specificity 98.6%• Overall sensitivity 91.2%• Lymphadenectomy rate 97.4% in
malignant epithelial cases• Overall metastasis to ovary from
elsewhere 4.8%, of which 77% were raised at the time of the FS
![Page 22: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist.](https://reader035.fdocuments.us/reader035/viewer/2022062713/56649ccc5503460f94996966/html5/thumbnails/22.jpg)
Summary - 2• Of the 1439 frozen sections reported here
(representing 1342 women), 94.5% of the women had the correct operative procedure at the initial surgical operation (that is staging or no-staging depending on the frozen section report).
• 4.3% of the women were under-staged at this first surgery, and required potentially a second procedure
• 1.2% of the women were over-staged based on the frozen section report
![Page 23: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist.](https://reader035.fdocuments.us/reader035/viewer/2022062713/56649ccc5503460f94996966/html5/thumbnails/23.jpg)
Summary - 3
• 19 false negatives(benign->malignant)– 7 interpretational errors– 12 sampling errors
• 3 false positive (malignant -> benign)– All interpretational errors
• Educational feedback always given after interpretational errors
• Sampling errors hard to fully eliminate
![Page 24: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist.](https://reader035.fdocuments.us/reader035/viewer/2022062713/56649ccc5503460f94996966/html5/thumbnails/24.jpg)
FS by categoriesNo %
• Epithelial 982 68.4– Serous 486 33.8– Mucinous 267 18.6– Endometrioid 151 10.5– Clear Cell 58 4– Brenner 20 1.4
• Sex-Cord stromal 138 9.6• Germ cell 78 5.4• Secondary 69 4.8• Benign non-neoplastic 169 11.8
![Page 25: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist.](https://reader035.fdocuments.us/reader035/viewer/2022062713/56649ccc5503460f94996966/html5/thumbnails/25.jpg)
Summary - 4
• Overall sampling errors depend on size/weight and type of ovarian lesion
• False negative rate for serous lesions is 0.7% and is for mucinous tumours 3.8%
• These two epithelial types accounted for 52.4% of FS overall
• Surgeons understand higher inherent error rate with mucinous lesions
![Page 26: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist.](https://reader035.fdocuments.us/reader035/viewer/2022062713/56649ccc5503460f94996966/html5/thumbnails/26.jpg)
Literature Comparison of PPV
No Ben% Bl% M% Defer%
Rose et al 383 92 65 99.1 -Yeo et al 316 98.2 - 100 -Cuello et al 842 98.2 - 96.7 -Twallfhoven et al 946 92 62 100 -Obiakor et al 311 95.3 - 100 2.6Lim et al 215 98.4 - 100 -Usubuton et al 360 92.1 - 93.1 3.3Pinto et al 243 93 61 93Gateshead 1439 92.9 53.1 98.8 0.4
![Page 27: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist.](https://reader035.fdocuments.us/reader035/viewer/2022062713/56649ccc5503460f94996966/html5/thumbnails/27.jpg)
Pathology FS Cost• Require cryostat (which most/all labs have)• Require
– availability of lab staff (about 25 mins per FS case)
– availability of Pathologist (about 10 mins per FS case)
• Availability can depend on geography of lab/offices and rotas
• Not a difficult skill to acquire to interpret • Consumables –
slides/blades/cryofreeze/stains - pence
![Page 28: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist.](https://reader035.fdocuments.us/reader035/viewer/2022062713/56649ccc5503460f94996966/html5/thumbnails/28.jpg)
Conclusion
• Ovarian frozen section service does work clinically but needs regular material, good team work and communication
• Good outcomes and can confidently be used to help manage the clinical situation
• Trusted by clinicians, pathologists and patients – the vast majority of women are correctly treated at first procedure (94.5% overall, 98.2% in the BL/malignant group)
![Page 29: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist.](https://reader035.fdocuments.us/reader035/viewer/2022062713/56649ccc5503460f94996966/html5/thumbnails/29.jpg)